98%
921
2 minutes
20
Porphyrin and iron are ubiquitous and essential for sustaining life in virtually all living organisms. Unlike iron, which exists in many forms, porphyrin macrocycles are mostly functional as metal complexes. The iron-containing porphyrin, heme, serves as a prosthetic group in a wide array of metabolic pathways; including respiratory cytochromes, hemoglobin, cytochrome P450s, catalases, and other hemoproteins. Despite playing crucial roles in many biological processes, heme, iron, and porphyrin intermediates are potentially cytotoxic. Thus, the intersection of porphyrin and iron metabolism at heme synthesis, and intracellular trafficking of heme and its porphyrin precursors are tightly regulated processes. In this review, we discuss recent advances in understanding the physiological dynamics of eukaryotic ferrochelatase, a mitochondrially localized metalloenzyme. Ferrochelatase catalyzes the terminal step of heme biosynthesis, the insertion of ferrous iron into protoporphyrin IX to produce heme. In most eukaryotes, except plants, ferrochelatase is localized to the mitochondrial matrix, where substrates are delivered and heme is synthesized for trafficking to multiple cellular locales. Herein, we delve into the structural and functional features of ferrochelatase, as well as its metabolic regulation in the mitochondria. We discuss the regulation of ferrochelatase via post-translational modifications, transportation of substrates and product across the mitochondrial membrane, protein-protein interactions, inhibition by small-molecule inhibitors, and ferrochelatase in protozoal parasites. Overall, this review presents insight on mitochondrial heme homeostasis from the perspective of ferrochelatase.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133952 | PMC |
http://dx.doi.org/10.3389/fcell.2022.894591 | DOI Listing |
Clin Auton Res
August 2025
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, 506 Robinson Research Building, Nashville, TN, 37232-880, USA.
Purpose: Postural orthostatic tachycardia syndrome (POTS) is characterized by an excessive heart rate increase upon standing, often associated with dizziness, gastrointestinal symptoms, and decreased functional capacity. Acute hepatic porphyrias (AHP) are rare metabolic disorders with nonspecific neurovisceral and autonomic symptoms, some of which overlap with POTS. The purpose of this study was to evaluate AHP by molecular and biochemical testing in patients with POTS.
View Article and Find Full Text PDFPhotodiagnosis Photodyn Ther
August 2025
School of Life Science and Technology, Institute of Science Tokyo, Midori-ku, Yokohama 2268501, Japan. Electronic address:
Background: 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) has emerged as a promising cancer treatment owing to its selectivity and minimal invasiveness. However, certain cancer types exhibit resistance to ALA-PDT, partly due to insufficient protoporphyrin Ⅸ (PpⅨ) accumulation. This study aimed to enhance PpⅨ accumulation by modulating iron metabolism.
View Article and Find Full Text PDFACS Omega
July 2025
School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.
Chocolate, derived from beans, is valued for its antioxidative benefits. However, little is known about cacao-derived peptides that counter oxidative stress. Ginsentides found in are cysteine-rich peptides that exhibit the "cure-all" health benefits of ginseng by coordinating multiple physiological systems to reduce cellular stress and damage.
View Article and Find Full Text PDFJ Clin Invest
July 2025
Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, United States of America.
Erythropoietic protoporphyria (EPP) is a genetic disorder typically resulting from decreased ferrochelatase (FECH) activity, the last enzyme in heme biosynthesis. Patients with X-linked protoporphyria (XLPP) have an overlapping phenotype caused by increased activity of 5-aminolevulinic acid synthase 2 (ALAS2), the first enzyme in erythroid heme synthesis. In both cases, protoporphyrin IX (PPIX) accumulates in erythrocytes and secondarily in plasma and tissues.
View Article and Find Full Text PDFOrphanet J Rare Dis
July 2025
Department of Gastroenterology, the Second Affiliated Hospital of Chongqing Medical University, No. 76, Linjiang Road, Yuzhong District, Chongqing, 400010, China.
Background: Erythropoietic protoporphyria is an inherited disorder characterized by mutations in the gene, which encodes the enzyme ferrous chelatase. These mutations disrupt normal heme synthesis, leading to the accumulation of protoporphyrin in erythrocytes and other tissues. Clinical manifestations include cutaneous photosensitivity, characterized by burning and itching of the skin, and, less commonly, liver failure.
View Article and Find Full Text PDF